Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis

Overview of attention for article published in BMC Pulmonary Medicine, July 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 5,989 followers.

RT @SamirNus: Patients with IPF benefit from drug antifibrotic therapy at early stages of disease (relatively preserved FVC) if they desatu…

RT @SamirNus: Patients with IPF benefit from drug antifibrotic therapy at early stages of disease (relatively preserved FVC) if they desatu…

RT @SamirNus: Patients with IPF benefit from drug antifibrotic therapy at early stages of disease (relatively preserved FVC) if they desatu…

RT @SamirNus: Patients with IPF benefit from drug antifibrotic therapy at early stages of disease (relatively preserved FVC) if they desatu…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.